BPG is committed to discovery and dissemination of knowledge
            
            
                
                
                    
    Articles Published Processes
    
        4/24/2022 7:32:05 AM | Browse: 558 | Download: 1048
    
    
        
        
    
        | 
                
                    |  | Received |  | 2021-08-29 08:56 | 
    
        | 
                
                    |  | Peer-Review Started |  | 2021-08-29 08:59 | 
    
        | 
                
                    |  | To Make the First Decision |  |  | 
    
        | 
                
                    |  | Return for Revision |  | 2021-09-29 19:11 | 
    
        | 
                
                    |  | Revised |  | 2021-10-09 09:06 | 
    
        | 
                
                    |  | Second Decision |  | 2022-03-22 06:37 | 
    
        | 
                
                    |  | Accepted by Journal Editor-in-Chief |  |  | 
    
        | 
                
                    |  | Accepted by Executive Editor-in-Chief |  | 2022-03-27 05:36 | 
    
        | 
                
                    |  | Articles in Press |  | 2022-03-27 05:36 | 
    
        | 
                
                    |  | Publication Fee Transferred |  |  | 
    
        | 
                
                    |  | Edit the Manuscript by Language Editor |  | 2022-03-18 23:27 | 
    
        | 
                
                    |  | Typeset the Manuscript |  | 2022-04-13 02:52 | 
            
                | 
                        
                            |  | Publish the Manuscript Online |  | 2022-04-24 07:32 | 
        
        
            
                | ISSN | 1007-9327 (print) and 2219-2840 (online) | 
            
                | Open Access | This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ | 
            
                | Copyright | ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. | 
                    
                        | Article Reprints | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247 | 
            
            
                | Permissions | For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207 | 
            
            
                | Publisher | Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | 
            
                | Website | http://www.wjgnet.com | 
        
    
        | Category | Virology | 
    
        | Manuscript Type | Letter to the Editor | 
    
        | Article Title | Viral hepatitis: A global burden needs future directions for the management | 
    
        | Manuscript Source | Invited Manuscript | 
    
        | All Author List | Henu Kumar verma, Kiran Prasad, Pramod Kumar and Bhaskar Lvks | 
            
                | ORCID |  | 
    
        | Funding Agency and Grant Number |  | 
    
        | Corresponding Author | Henu Kumar verma, PhD, Research Scientist, Senior Researcher, Department of Immunopathology, Institute of Lungs Biology and Disease, Comprehensive Pneumology Center, Helmholtz Zentrum, 85764 Neuherberg, Munich 80331, Germany. henu.verma@yahoo.com | 
    
        | Key Words | Viral hepatitis; Vaccination; Chronic; Acute; Viral therapy | 
    
        | Core Tip | Vaccination is the primary strategy for neutralizing several hepatitis viruses and it is highly effective against most hepatitis viruses. However, additional precautions must be taken for patients at a higher risk of infection such as those who take drugs, prisoners, the homeless or homosexuals. From interferon monotherapy and interferon combination therapy with direct-acting antiviral agents to interferon-free regimens which act by viral chain braking are among the measures to control hepatitis. These strategies can play a critical role in achieving World Health Organization's an ambitious but attainable goal of eliminating hepatitis infection by 2030. | 
            
                | Publish Date | 2022-04-24 07:32 | 
    
        | Citation | Verma HK, Prasad K, Kumar P, Lvks B. Viral hepatitis: A global burden needs future directions for the management. World J Gastroenterol 2022; 28(16): 1718-1721 | 
            
                | URL | https://www.wjgnet.com/1007-9327/full/v28/i16/1718.htm | 
            
                | DOI | https://dx.doi.org/10.3748/wjg.v28.i16.1718 | 
    
    
        
                
        
     
 
                 
             
         
        
    
        
        
            © 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
            California Corporate Number: 3537345